Back to Search
Start Over
Percutaneous coronary intervention outcomes based on American College of Cardiology/American Heart Association coronary lesion classification over 14 years - Melbourne interventional group (MIG) registry.
- Source :
-
Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Dec; Vol. 69, pp. 52-59. Date of Electronic Publication: 2024 Jun 11. - Publication Year :
- 2024
-
Abstract
- Background: The American College of Cardiology / American Heart Association (ACC/AHA) introduced a coronary lesion classification in 1988 to stratify coronary lesions for probability of procedural success and complications after coronary angioplasty. Our aim is to assess the validity of the ACC/AHA lesion classification in predicting outcomes of percutaneous coronary intervention (PCI) in a contemporary cohort of patients.<br />Methods: Consecutive PCI procedures performed between 2005 and 2018, were divided into three periods. At each period, the ACC/AHA lesion classification (A, B1, B2, C) was analysed with respect to procedural characteristics, in-hospital and 30-day outcomes, as well as long-term mortality by linkage to the National Death Index (NDI).<br />Results: In total, 21,437 lesions were included with 7399 lesions (2005-2009), 6917 lesions (2010-2014) and 7121 lesions (2015-2018). There was a progressive increase in the number of complex lesions treated over time with ACC/AHA type C (15 %, 21 % and 26 %, p < 0.01). The rate of PCI procedural success decreased with increase in the complexity of lesions treated across all three periods (p < 0.01). Further, in-hospital and 30-day major adverse cardiovascular events (MACE), major adverse cardiac and cerebrovascular events (MACCE) increased across all three time periods (all p < 0.05).<br />Conclusions: Our study validates the ACC/AHA lesion classification as a meaningful tool for prediction of PCI outcomes. Despite advances in PCI techniques and technology, complex lesion PCI defined by this classification continues to be associated with adverse outcomes.<br />Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dion Stub reports a relationship with National Heart Foundation of Australia that includes: funding grants. Dion Stub reports a relationship with National Health and Medical Research Council that includes: funding grants. Disclosure A/Prof. Dion Stub is supported by the National Heart Foundation of Australia and Australian National Health and Medical Research Council fellowships.<br /> (Copyright © 2024. Published by Elsevier Inc.)
- Subjects :
- Humans
Male
Female
Time Factors
Aged
Treatment Outcome
Middle Aged
Risk Factors
Risk Assessment
Hospital Mortality
American Heart Association
Victoria
Reproducibility of Results
United States
Retrospective Studies
Aged, 80 and over
Percutaneous Coronary Intervention adverse effects
Percutaneous Coronary Intervention mortality
Registries
Coronary Artery Disease therapy
Coronary Artery Disease diagnostic imaging
Coronary Artery Disease mortality
Predictive Value of Tests
Subjects
Details
- Language :
- English
- ISSN :
- 1878-0938
- Volume :
- 69
- Database :
- MEDLINE
- Journal :
- Cardiovascular revascularization medicine : including molecular interventions
- Publication Type :
- Academic Journal
- Accession number :
- 38876940
- Full Text :
- https://doi.org/10.1016/j.carrev.2024.06.010